RedHill Biopharma (RDHL) EPS (Diluted) (2012 - 2023)
RedHill Biopharma (RDHL) EPS (Diluted) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 7.27 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.39 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.15 |
| Mar 31, 2023 | -0.36 |
| Dec 31, 2022 | -3.18 |
| Sep 30, 2022 | -0.98 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2021 | 58.13 |
| Dec 31, 2020 | 45.57 |
| Sep 30, 2020 | 44.47 |
| Jun 30, 2020 | 38.72 |
| Mar 31, 2020 | 71.14 |
| Dec 31, 2019 | 51.20 |
| Sep 30, 2019 | 44.20 |
| Jun 30, 2019 | 61.09 |
| Mar 31, 2019 | 37.01 |
| Dec 31, 2018 | 53.64 |
| Mar 31, 2018 | 56.94 |
| Dec 31, 2017 | 103.74 |
| Sep 30, 2017 | 72.33 |
| Mar 31, 2017 | 90.12 |
| Dec 31, 2016 | 0.00 |